Document ID: chunk:federal_register_of_legislation:F2022L01379:reg:9:p1
Version: federal_register_of_legislation:F2022L01379
Segment Type: reg
Provision Reference: reg 9 (pt 1/2)
Character Range: 4380–7311

9               Factors that must exist
At least one of the following factors must as a minimum exist before it can be said that a reasonable hypothesis has been raised connecting malignant neoplasm of unknown primary site or death from malignant neoplasm of unknown primary site with the circumstances of a person's relevant service:
(1)          having smoked tobacco products:
(a)           in an amount of at least 10 pack-years before the clinical onset of malignant neoplasm of unknown primary site; and
(b)           commencing at least 5 years before the clinical onset of malignant neoplasm of unknown primary site; and
if smoking has ceased before the clinical onset of malignant neoplasm of unknown primary site, then that onset occurred within 20 years of cessation;
Note: one pack-year is defined in the Schedule 1 - Dictionary.
(2)          consuming alcohol:
(a)          in an amount of at least 200 kilograms before the clinical onset of malignant neoplasm of unknown primary site; and
(b)          where consumption of alcohol commenced at least 5 years before the clinical onset of malignant neoplasm of unknown primary site; and
if consumption of alcohol has ceased before the clinical onset of malignant neoplasm of unknown primary site, then that onset occurred within 40 years of cessation;
Note: Alcohol consumption is calculated utilising the Australian Standard of 10 grams of alcohol per standard alcoholic drink.
(3)          having received a cumulative equivalent dose of at least 0.1 sievert of ionising radiation to at least one location in the body, at least 5 years before the clinical onset of malignant neoplasm of unknown primary site;
Note: cumulative equivalent dose is defined in the Schedule 1 – Dictionary.
(4)          for squamous cell carcinoma of unknown primary site of the head and neck only, having infection of the epithelium of the:
(a)          oral cavity;
(b)          oropharynx; or
(c)          larynx;
with human papillomavirus type 16 or 18 before the clinical onset of malignant neoplasm of unknown primary site;
Note: squamous cell carcinoma of unknown primary site of the head and neck is defined in the Schedule 1 - Dictionary.
(5)          for squamous cell carcinoma of unknown primary site involving the inguinal lymph nodes only, having infection of the epithelium of the:
(a)          anus or anal canal;
(b)          cervix;
(c)          penis;
(d)          vagina; or
(e)          vulva;
with a specified human papillomavirus before the clinical onset of malignant neoplasm of unknown primary site;
Note: specified human papillomavirus is defined in the Schedule 1 - Dictionary.
(6)          for squamous cell carcinoma of unknown primary site of the head and neck only, having infection with Epstein-Barr virus before the clinical onset of malignant neoplasm of unknown primary site;
Note: squamous cell carcinoma of unknown primary site of the head and neck is